Want to join the conversation?
$CBG continued to make gains through investments in recruiting, training, technology, branding and research positioned to help deliver great outcomes for clients and drive growth. The services business, comprised of the Americas, EMEA and APAC regions posted revenue and normalized EBITDA growth with solid margin expansion.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.